Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002033801-24-000003·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Common Stock, $0.001 par value · CUSIP: 38000Q102
Event date: 2024-10-30
- Filing-level shares
- 50,000.00
- Percent of class
- 0.1%
- Weinstein Benjamin
Shares: 50,000.00 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002033801-24-000003
- Form type
- SCHEDULE 13G/A
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Nov 04, 2024
- Reporting period
- Oct 30, 2024
- Description
- Schedule 13G beneficial ownership